We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Antibody-based COVID-19 Diagnostic Test Receives CE Mark content piece image
Product News

Antibody-based COVID-19 Diagnostic Test Receives CE Mark

The Anti-SARS-CoV-2 ELISAs for immunoglobulin classes A and G from EUROIMMUN, a PerkinElmer, Inc. company, have received the CE mark and can now be applied to COVID-19 diagnostics.
SOPHiA GENETICS and Paragon Genomics Join Forces Against the Coronavirus Pandemic content piece image
Product News

SOPHiA GENETICS and Paragon Genomics Join Forces Against the Coronavirus Pandemic

SOPHiA GENETICS has announced that it is entering the fight against the COVID-19 coronavirus by extending its partnership with Paragon Genomics, who developed a next-generation sequencing (NGS) assay and leveraging the SOPHiA Platform analytical capabilities, as well as delivering the benefits of this solution to its install base of over 1,000 hospitals worldwide in the next weeks.
Fast and Reliable Tracking of Coronavirus Patient Samples content piece image
Product News

Fast and Reliable Tracking of Coronavirus Patient Samples

Ziath Ltd. has received orders for its DataPaq™ Mirage Rack Scanner from a growing number of laboratories that specialize in testing patient samples for COVID-19.
Mologic and Partners Begin Validation Process for COVID-19 Point-of-need Diagnostic Test content piece image
Product News

Mologic and Partners Begin Validation Process for COVID-19 Point-of-need Diagnostic Test

Mologic Ltd has announced that it has initiated early validation of COVID-19 point-of-need diagnostic tests with the Liverpool School of Tropical Medicine and St Georges’ University London.
SARS-CoV-2 Gene Variants Provide Clues to Coronavirus’ Epidemiology content piece image
Product News

SARS-CoV-2 Gene Variants Provide Clues to Coronavirus’ Epidemiology

Scientists say early data, generated with new NGS research panel from Thermo Fisher Scientific, suggest coronavirus is genetically stable and could increase the effectiveness of vaccines in development.
Sartorius Supports the Development of SARS-CoV-2 Vaccine Candidate content piece image
Product News

Sartorius Supports the Development of SARS-CoV-2 Vaccine Candidate

Sartorius has supported CanSino Biologics Inc. and Maj. Gen. Chen Wei’s team at the Institute of Bioengineering at the Academy of Military Medical Sciences in China in their development of the first vaccine candidate against the novel coronavirus SARS-CoV-2 to enter clinical trials.
FDA Provides Emergency Use Authorization to PerkinElmer for COVID-19 Testing content piece image
Product News

FDA Provides Emergency Use Authorization to PerkinElmer for COVID-19 Testing

PerkinElmer has announced that the U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for the company’s new Coronavirus RT-PCR test.
Free Safety Testing in Human Liver Models for Exploratory COVID-19 Treatments content piece image
Product News

Free Safety Testing in Human Liver Models for Exploratory COVID-19 Treatments

InSphero has announced that it will offer free safety testing, based on human liver models, for exploratory COVID-19 medications and coronavirus (SARS-CoV-2) vaccine formulations.
Heat Biologics and University of Miami Collaborate to Develop COVID-19 Diagnostic Test content piece image
Product News

Heat Biologics and University of Miami Collaborate to Develop COVID-19 Diagnostic Test

Heat Biologics is collaborating with the University of Miami to develop a proprietary UM COVID-19 point-of-care diagnostic test.
Promising Phase 2a Data on Prostate Cancer Immunotherapy content piece image
Product News

Promising Phase 2a Data on Prostate Cancer Immunotherapy

Vaccitech Limited and the University of Oxford have announced initial efficacy and safety data for ADVANCE, a Phase 2a study testing VTP-800, an immunotherapeutic product candidate in patients with metastatic castration resistant prostate cancer (mCRPC).
Advertisement